Tigecycline is efficacious in the treatment of complicated intra-abdominal infections
- 31 December 2005
- journal article
- Published by Elsevier in International Journal of Surgery
- Vol. 3 (1), 35-47
- https://doi.org/10.1016/j.ijsu.2005.03.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgeryEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal InfectionsClinical Infectious Diseases, 2003
- Community-Acquired Bloodstream Infection in Critically Ill Adult PatientsChest, 2003
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- In Vitro and In Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents against Glycopeptide-IntermediateStaphylococcus aureusand Other Resistant Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2002
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Antibiotic-Resistant Enterococci and the Changing Face of Surgical InfectionsArchives of Surgery, 1996
- Intraabdominal InfectionsClinical Infectious Diseases, 1993
- The Bacteriology of Intra-abdominal InfectionsSurgical Clinics of North America, 1975